Nectar Lifesciences Ltd is primarily engaged in the development, manufacture and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.
Categories
API
Themis Medicare Ltd Q1FY24; 6% rise in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results:
Mangalam Drugs and Organics Ltd Q1FY24; 20% fall in Revenue
Mangalam Drugs & Organics Limited is engaged in manufacturing pharma APIs, Intermediates and Specialty Chemicals. Financial Results: Mangalam Drugs and Organics Ltd
Shilpa Medicare Ltd Q1FY24; 50% fall in Profits
Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech
Granules India Ltd Q1FY24; 62% fall in Profits
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates
Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
SMS Pharmaceuticals Ltd Q1FY24; 110% rise in Revenue
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. Financial Results: SMS
Morepen Laboratories Ltd Q1FY24; 150% rise in Profits
Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs),
NGL Fine Chem Ltd Q1FY24; 1431% rise in Profits
Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It
Vaishali Pharma Ltd Q1FY24; 5% rise in Profits
Incorporated in 1989, Vaishali Pharma Ltd. is engaged in the manufacturing, trading & marketing of Active Pharmaceutical Ingredients(APIs), pharmaceuticals formulations, surgical products,
Par Drugs & Chemicals Ltd Q1FY24; 8% rise in Profits
Par Drugs & Chemicals Ltd is primarily engaged in manufacturing of Active Pharma Ingredients (APIs) and fine chemicals for domestic & international
Supriya Lifescience Ltd Q1FY24; 16% rise in Profits
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Sun Pharmaceuticals Industries Ltd Q1FY24; 4% fall in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
RPG Life Sciences Ltd Q1FY24; 22% rise in Profits
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in
Unichem Laboratories Ltd Q1FY24; 37% rise in Revenue
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd reported Revenues
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth
Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35%
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL
Divi’s Laboratories Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked if backward
Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Solara Active Pharma Q4FY23 results out, revenue grows by 6%
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Tanla Platform Q4FY23 results out, revenue drops by 2%
Tanla Platforms Ltd (formerly Tanla Solutions Ltd) is a cloud communications provider enabling businesses to communicate with their customers and intended recipients.